Published 4 days ago • loading... • Updated 4 days agoShow Less IconBTIG Research Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) Stock Summary by MarketBeatBTIG Research lifted their price objective on shares of AtriCure from $55.00 to $63.00 and gave the company a "buy" rating in a research note on Monday.Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconMarketBeatCenterFactualityOwnershipBTIG Research Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) StockBTIG Research lifted their price objective on shares of AtriCure from $55.00 to $63.00 and gave the company a "buy" rating in a research note on Monday.4 days ago·Sioux Falls, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated4 days agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageMarketBeat broke the news in Sioux Falls, United States 4 days ago on Monday, October 12, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsMason, Ohio Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsMason, Ohio Plus IconShow All